BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6582585)

  • 21. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
    Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
    Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
    Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
    Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dose intravenous gammaglobulin and platelet transfusions in leukaemic HLA-immunized patients.
    Bierling P; Cordonnier C; Rodet M; Vernant JP; Pesce A; Rochant H; Duedari N
    Scand J Haematol; 1984 Aug; 33(2):215-20. PubMed ID: 6206554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates.
    Peter-Salonen K; Bucher U; Nydegger UE
    Blut; 1987 Apr; 54(4):207-12. PubMed ID: 3828538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
    Chambers LA; Kruskall MS; Pacini DG; Donovan LM
    Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.
    Bercovitz RS; O'Brien SH
    Hematology Am Soc Hematol Educ Program; 2012; 2012():157-60. PubMed ID: 23233575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New approaches to an old problem. Refractoriness to platelet transfusions.
    Aster RH
    Transfusion; 1988; 28(2):95-6. PubMed ID: 3354053
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
    Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
    Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The appropriateness of platelet transfusions in hematological patients and the potential for improvement.
    Liker M; Bašić Kinda S; Duraković N; Bojanić I; Aurer I; Golubić Ćepulić B
    Transfus Clin Biol; 2023 May; 30(2):212-218. PubMed ID: 36493919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based platelet transfusion guidelines.
    Slichter SJ
    Hematology Am Soc Hematol Educ Program; 2007; ():172-8. PubMed ID: 18024626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet transfusion from donors mismatched for crossreactive HLA antigens.
    Dahlke MB; Weiss KL
    Transfusion; 1984; 24(4):299-302. PubMed ID: 6464151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of platelets in transfusion medicine.
    Brubaker DB
    J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
    Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
    Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis.
    Cairo MS; Worcester C; Rucker R; Bennetts GA; Amlie R; Perkin R; Anas N; Hicks D
    J Pediatr; 1987 Jun; 110(6):935-41. PubMed ID: 3585610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods.
    Apelseth TO; Bruserud O; Wentzel-Larsen T; Hervig T
    Transfusion; 2010 Apr; 50(4):766-75. PubMed ID: 20030789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.